ecancer

Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer

Dr Katie Kelley - University of California San Francisco, San Francisco, USA

2 May 2023

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC

Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

27 Apr 2023

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA

26 Apr 2023

Higher BMI may be linked with worse survival among SBS88 positive CRC patients

Dr Claire Thomas - Fred Hutchinson Cancer Center, Seattle, USA

20 Apr 2023

Key practices for handling difficult conversations in cancer care

Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila, Philippines

19 Apr 2023

Choosing wisely in complementary treatment for cancer in the Philippines

Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines

19 Apr 2023

A multidisciplinary team approach to cancer care in the Philippines

Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines

12 Apr 2023

Choosing the right serum and molecular biomarkers in the Philippines

Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines

12 Apr 2023

Latest treatments in oesophageal cancer

Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA

5 Apr 2023

PSMO and the future of cancer care in the Philippines

Dr Rosario Pitargue - Philippine Society of Medical Oncology, Manila, Philippines

4 Apr 2023

Low value practices that result in poor patient outcomes in LMICs

Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines

4 Apr 2023

Key methods for handling difficult conversations in cancer care

Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila, Philippines

4 Apr 2023

More from ecancer